Henry Schein, Inc. $HSIC Shares Sold by Baird Financial Group Inc.

Baird Financial Group Inc. reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 24.9% in the 1st quarter, Holdings Channel.com reports. The firm owned 4,086 shares of the company’s stock after selling 1,352 shares during the quarter. Baird Financial Group Inc.’s holdings in Henry Schein were worth $280,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HSIC. Vident Advisory LLC increased its position in shares of Henry Schein by 45.8% during the first quarter. Vident Advisory LLC now owns 5,120 shares of the company’s stock valued at $351,000 after acquiring an additional 1,608 shares during the last quarter. Magnetar Financial LLC acquired a new stake in shares of Henry Schein during the first quarter valued at about $1,809,000. State of Wyoming increased its position in shares of Henry Schein by 205.1% during the first quarter. State of Wyoming now owns 11,335 shares of the company’s stock valued at $776,000 after acquiring an additional 7,620 shares during the last quarter. Trexquant Investment LP increased its position in shares of Henry Schein by 27.3% during the first quarter. Trexquant Investment LP now owns 11,213 shares of the company’s stock valued at $768,000 after acquiring an additional 2,403 shares during the last quarter. Finally, Zuckerman Investment Group LLC increased its position in shares of Henry Schein by 69.6% during the first quarter. Zuckerman Investment Group LLC now owns 201,639 shares of the company’s stock valued at $13,810,000 after acquiring an additional 82,779 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Up 3.2%

Shares of NASDAQ:HSIC opened at $69.55 on Friday. The firm has a 50 day simple moving average of $69.44 and a 200-day simple moving average of $69.53. The company has a market capitalization of $8.43 billion, a PE ratio of 22.44, a P/E/G ratio of 2.22 and a beta of 0.86. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business’s revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on HSIC. Wall Street Zen cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Sunday, September 7th. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research report on Wednesday, August 6th. Baird R W lowered shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 14th. Stifel Nicolaus reissued a “hold” rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Barrington Research lowered their price objective on shares of Henry Schein from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Wednesday, August 6th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.